Search results for: Innovation Policy Prize
Filter search results
QALYs versus Experience: A Perspective from Experimental Economics
1 August 2008
OHE’s 14th Annual Lecture was delivered by Professor Daniel Kahneman, winner of the 2002 Nobel Prize in Economic Sciences for his pioneering work integrating insights from psychological research into economic…
Mental Health Economics and Policy in a Global Context
1 December 2003
…health policy in low and middle income countries. Health economists have a growing voice in health policy development. But just as it is only recently that mental health policy specifically…
OHE Lunchtime Seminar: Closing the ‘Know-do’ Gap for Health Systems Reform at the Policy Level
5 September 2019
…how policy is formed and implemented, public health, and health systems transformation. Between 1999 and July 2017, David was Director of the Centre for Public Policy and Health at Durham…
The CBO Doesn’t Understand Investors
13 September 2021
…innovation (i.e., the relationship between a reduction in revenue and outputs of innovation) to expected revenues based on estimates from the academic literature at an aggregate industry level. Our later…
Seminar Briefing on Science Policy
23 December 2010
…Policy Studies at SPRU, University of Sussex) presented the results of his extensive literature review and qualitative research on how the field of science policy research has evolved and advanced in the…
New: Pay-for-Performance for Drugs and Incentives for Innovation
27 February 2012
…for innovation. Download Towse, A., Garrison, L. and Puig-Peiró, R. The use of pay-for-performance for drugs: Can it improve incentives for innovation? Occasional Paper. 12/01. London: Office of Health Economics….
The value of cell and gene therapies to the UK economy
20 October 2025
…Slower progression, reduced care burden * Estimates represent the incremental monetised value of outcomes over 10 years Implications For policymakers, the results signal the scale of the prize and the potential…
Victoria Jordan
3 February 2023
Victoria Jordan is Head of HTA and Market Access Policy at the Association of the British Pharmaceutical Industry (ABPI) which he joined in November 2017.
Around The World in HTAs: France – Three Core HTA Values
12 March 2026
…GDP) and prescription medicines (public coverage of more than 80% of pharmaceutical costs), France offers high accessibility to pharmaceutical and health innovation. Recent reforms, such as the 100% santé reform, aim…